Increased vulnerability of dopaminergic neurons in MPTP-lesioned interleukin-6 deficient mice

被引:85
作者
Bolin, LM [1 ]
Strycharska-Orczyk, I [1 ]
Murray, R [1 ]
Langston, JW [1 ]
Di Monte, D [1 ]
机构
[1] Parkinsons Inst, Sunnyvale, CA 94089 USA
关键词
gliosis; interleukin-6; MPTP; neuroinflammation; Parkinson's disease;
D O I
10.1046/j.1471-4159.2002.01131.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To test the hypothesis that neuroinflammation contributes to dopaminergic neuron death in the MPTP-lesioned mouse, we compared nigrostriatal degeneration in interleukin (IL)-6 (+/+) with IL-6 (-/-) mice. In the absence of IL-6, a single injection of MPTP (30 mg/kg) resulted in significantly greater striatal dopamine depletion than that measured in IL-6 (+/+) mice. The observed dopamine depletion was MPTP dose dependent. This loss of striatal dopamine and a significantly greater loss of TH+ cells in the substantia nigra pars compacta in IL-6 (-/-) mice as compared with control IL-6 (+/+) mice, suggest that IL-6 is neuroprotective in the MPTP-lesioned nigrostriatal system. Co-localization experiments identified striatal astrocytes as the source of IL-6 in IL-6 (+/+) mice at 1 and 7 days postinjection of MPTP. The increased sensitivity of dopaminergic neurons to neurotoxicant in the absence of IL-6, is compatible with a neuroprotective activity of IL-6 in the injured nigrostriatal system.
引用
收藏
页码:167 / 175
页数:9
相关论文
共 72 条
  • [1] ADERKA D, 1989, J IMMUNOL, V143, P3517
  • [2] Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease
    Banati, RB
    Daniel, SE
    Blunt, SB
    [J]. MOVEMENT DISORDERS, 1998, 13 (02) : 221 - 227
  • [3] INTERLEUKIN-6 IN CLINICAL MEDICINE
    BAUER, J
    HERRMANN, F
    [J]. ANNALS OF HEMATOLOGY, 1991, 62 (06) : 203 - 210
  • [4] NEUROPOIETIC CYTOKINES IN THE HEMATOPOIETIC FOLD
    BAZAN, JF
    [J]. NEURON, 1991, 7 (02) : 197 - 208
  • [5] Bhat NR, 1998, J NEUROSCI, V18, P1633
  • [6] Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients
    BlumDegen, D
    Muller, T
    Kuhn, W
    Gerlach, M
    Przuntek, H
    Riederer, P
    [J]. NEUROSCIENCE LETTERS, 1995, 202 (1-2) : 17 - 20
  • [7] MICROGLIAL-PRODUCED NITRIC-OXIDE AND REACTIVE NITROGEN-OXIDES MEDIATE NEURONAL CELL-DEATH
    BOJE, KM
    ARORA, PK
    [J]. BRAIN RESEARCH, 1992, 587 (02) : 250 - 256
  • [8] IMMUNOCYTOCHEMICAL ANALYSIS OF TUMOR-NECROSIS-FACTOR AND ITS RECEPTORS IN PARKINSONS-DISEASE
    BOKA, G
    ANGLADE, P
    WALLACH, D
    JAVOYAGID, F
    AGID, Y
    HIRSCH, EC
    [J]. NEUROSCIENCE LETTERS, 1994, 172 (1-2) : 151 - 154
  • [9] Chan P, 1997, J PHARMACOL EXP THER, V280, P439
  • [10] CHAO CC, 1992, J IMMUNOL, V149, P2736